Literature DB >> 23933739

Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients.

Ryoichi Nakamura1, Naoki Atsuta, Hazuki Watanabe, Akihiro Hirakawa, Hirohisa Watanabe, Mizuki Ito, Jo Senda, Masahisa Katsuno, Fumiaki Tanaka, Yuishin Izumi, Mitsuya Morita, Kotaro Ogaki, Akira Taniguchi, Ikuko Aiba, Koichi Mizoguchi, Koichi Okamoto, Kazuko Hasegawa, Masashi Aoki, Akihiro Kawata, Koji Abe, Masaya Oda, Masaaki Konagaya, Takashi Imai, Masanori Nakagawa, Shoji Tsuji, Ryuji Kaji, Imaharu Nakano, Gen Sobue.   

Abstract

OBJECTIVE: To clarify the emergence of muscle weakness in regions of the body that affect survival, and deterioration in activities of daily living (ADL) in amyotrophic lateral sclerosis (ALS) patients.
METHODS: We conducted a multicentre-based prospective cohort study of patients with ALS. We enrolled 401 sporadic patients with ALS. Death or the introduction of invasive ventilation was defined as the primary endpoint, and the time to five clinical markers of ADL deterioration associated with bulbar paralysis or limb weakness were defined as ADL milestones. Muscle weakness was assessed in the neck flexor muscles; the bilateral abductors of the shoulders; the bilateral wrist extensor muscles; the bilateral flexor muscles of the hips; and the bilateral ankle dorsiflexion muscles. We performed Cox proportional hazards regression analyses for the primary endpoint and the five ADL milestones, adjusting for known covariate prognostic factors for ALS.
RESULTS: The Medical Research Council (MRC) score for the neck flexors was the most significant prognostic factor for the primary endpoint (HR 0.74, p<0.001), loss of speech (HR 0.66, p<0.001), and loss of swallowing function (HR 0.73, p<0.001), and was one of the significant prognostic factors for loss of upper limb function, difficulty turning in bed, and loss of walking ability (p=0.001, 0.002, and 0.008, respectively). The MRC score for the neck flexors was also a significant prognostic factor for covariates of the previously reported prognostic factors.
CONCLUSIONS: Neck weakness is an independent prognostic factor for survival and deterioration in ADL in Patients with ALS.

Entities:  

Keywords:  ALS; Clinical Neurology; Neuroepidemiology

Mesh:

Substances:

Year:  2013        PMID: 23933739     DOI: 10.1136/jnnp-2013-306020

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

Review 1.  Mechanisms of compensatory plasticity for respiratory motor neuron death.

Authors:  Yasin B Seven; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2019-01-06       Impact factor: 1.931

2.  Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis.

Authors:  Daichi Yokoi; Naoki Atsuta; Hazuki Watanabe; Ryoichi Nakamura; Akihiro Hirakawa; Mizuki Ito; Hirohisa Watanabe; Masahisa Katsuno; Yuishin Izumi; Mitsuya Morita; Akira Taniguchi; Masaya Oda; Koji Abe; Kouichi Mizoguchi; Osamu Kano; Satoshi Kuwabara; Ryuji Kaji; Gen Sobue
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

3.  Compensatory plasticity in diaphragm and intercostal muscle utilization in a rat model of ALS.

Authors:  Yasin B Seven; Nicole L Nichols; Mia N Kelly; Orinda R Hobson; Irawan Satriotomo; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2017-10-19       Impact factor: 5.330

4.  Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Mirian Conceicao Moura; Maria Rita Carvalho Garbi Novaes; Emanoel Junio Eduardo; Yuri S S P Zago; Ricardo Del Negro Barroso Freitas; Luiz Augusto Casulari
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

5.  An Objective Functional Characterisation of Head Movement Impairment in Individuals with Neck Muscle Weakness Due to Amyotrophic Lateral Sclerosis.

Authors:  Silvia Pancani; Wendy Tindale; Pamela J Shaw; Christopher J McDermott; Claudia Mazzà
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

6.  The clinical assessment of amyotrophic lateral sclerosis patients' prognosis by ZNF512B gene, neck flexor muscle power score and body mass index (BMI).

Authors:  Chun-Jiang Yu; Li Wang; Sen-Lin Mao; Ying Zhang; Ling-Ling Song; Ling-Yu Cai; Ye Tao
Journal:  BMC Neurol       Date:  2018-12-19       Impact factor: 2.474

7.  A robotic neck brace to characterize head-neck motion and muscle electromyography in subjects with amyotrophic lateral sclerosis.

Authors:  Haohan Zhang; Biing-Chwen Chang; Jinsy Andrews; Hiroshi Mitsumoto; Sunil Agrawal
Journal:  Ann Clin Transl Neurol       Date:  2019-08-07       Impact factor: 4.511

8.  Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis.

Authors:  Kensuke Ikenaka; Yasuhiro Maeda; Yuji Hotta; Seiichi Nagano; Shinichiro Yamada; Daisuke Ito; Ryota Torii; Keita Kakuda; Harutsugu Tatebe; Naoki Atsuta; Cesar Aguirre; Yasuyoshi Kimura; Kousuke Baba; Takahiko Tokuda; Masahisa Katsuno; Kazunori Kimura; Gen Sobue; Hideki Mochizuki
Journal:  Eur J Neurol       Date:  2022-02-06       Impact factor: 6.288

Review 9.  Quantifying disease progression in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Martin R Turner; Steve Vucic; Ammar Al-Chalabi; Jeremy Shefner; Catherine Lomen-Hoerth; Matthew C Kiernan
Journal:  Ann Neurol       Date:  2014-09-30       Impact factor: 10.422

10.  A clinical tool for predicting survival in ALS.

Authors:  Jonathan A Knibb; Noa Keren; Anna Kulka; P Nigel Leigh; Sarah Martin; Christopher E Shaw; Miho Tsuda; Ammar Al-Chalabi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2016-07-04       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.